Cybin Inc. Common Stock
HELP
Rangering i aksjer
#11616
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Aksjekurs
$10.30
Sist synkronisert: 2026-08-11
Markedsverdi
$638.32M
Endring (1 dag)
2.88%
Endring (1 år)
9,119.52%
Land
CA
Handel Cybin Inc. Common Stock (HELP)
Kategori
Healthcare
Markedsverdi av Cybin Inc. Common Stock(HELP)
Markedsverdi: $638.32M
Per October 2026 har Cybin Inc. Common Stock en markedsverdi på $638.32M. Dette gjør Cybin Inc. Common Stock til det 11616th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Cybin Inc. Common Stock fra 2021 til 2026
HELP sammenlignet med topp 5 mest populære stocks
